BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tambasco N, Mastrodicasa E, Salvatori C, Mancini G, Romoli M, Caniglia M, Calabresi P, Verrotti A. Prognostic factors in children with PRES and hematologic diseases. Acta Neurol Scand 2016;134:474-83. [PMID: 26876986 DOI: 10.1111/ane.12570] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Pringle C, Portwood K, Viamonte MA, Rajderkar D. Imaging findings in neonatal and pediatric Posterior Reversible Encephalopathy Syndrome (PRES) differ from adults. Pediatric Neurology 2022. [DOI: 10.1016/j.pediatrneurol.2022.06.022] [Reference Citation Analysis]
2 Hafez HA, Ragab I, Sedky M, Shams M, Youssef A, Refaat A, Habib E, Sidhom I. Patterns, risk factors and outcome predictors of posterior reversible encephalopathy syndrome in pediatric cancer patients. Leuk Lymphoma 2021;62:462-8. [PMID: 33063564 DOI: 10.1080/10428194.2020.1832658] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Cordelli DM, Marra C, Ciampoli L, Barbon D, Toni F, Zama D, Giordano L, Milito G, Sartori S, Sainati L, Foiadelli T, Mina T, Fusco L, Santarone M, Iurato C, Orsini A, Farello G, Verrotti A, Aceti A, Masetti R. Posterior Reversible Encephalopathy Syndrome in infants and young children. Eur J Paediatr Neurol 2021;30:128-33. [PMID: 33139147 DOI: 10.1016/j.ejpn.2020.10.009] [Reference Citation Analysis]
4 Gao B, Lyu C, Lerner A, McKinney AM. Controversy of posterior reversible encephalopathy syndrome: what have we learnt in the last 20 years? J Neurol Neurosurg Psychiatry 2018;89:14-20. [PMID: 28794149 DOI: 10.1136/jnnp-2017-316225] [Cited by in Crossref: 71] [Cited by in F6Publishing: 57] [Article Influence: 14.2] [Reference Citation Analysis]
5 Goyal G, Jeswani J. Study of Clinico-radiological Profile in Posterior Reversible Encephalopathy Syndrome: Experience from North India. Indian Journal of Critical Care Medicine 2022;26:501-5. [DOI: 10.5005/jp-journals-10071-24172] [Reference Citation Analysis]
6 Dulamea AO, Lupescu IG. Neurological complications of hematopoietic cell transplantation in children and adults. Neural Regen Res. 2018;13:945-954. [PMID: 29926815 DOI: 10.4103/1673-5374.233431] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
7 Hun M, Tian J, Xie M, She Z, Abdirahman AS, Han P, Wan W, Wen C. Analysis of Risk Factors Associated With Poor Outcome in Posterior Reversible Encephalopathy Syndrome After Treatment in Children: Systematic Review and Meta-Analysis. Front Neurol 2020;11:938. [PMID: 32982945 DOI: 10.3389/fneur.2020.00938] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Joshi S, Krstacic J, Mallangada N, Coriolan S, Karampahtsis C. Letter to the Editor: Management of Psychiatric Manifestations in a Case of Pediatric Posterior Reversible Encephalopathy Syndrome Due to Chemotherapy. J Child Adolesc Psychopharmacol 2020;30:621. [PMID: 33035071 DOI: 10.1089/cap.2020.0066] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Danhofer P, Tomečková M, Černá D, Zapletalová D, Horák O, Aulická Š, Juříková L, Domanský J, Kovalčíková P, Pavlík T, Štěrba J, Ošlejšková H. Prognostic factors and seizure outcome in posterior reversible encephalopathy syndrome (PRES) in children with hematological malignancies and bone marrow failure: A retrospective monocentric study. Seizure 2019;72:1-10. [PMID: 31521834 DOI: 10.1016/j.seizure.2019.08.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Duarte CM, Vilardouro AS, Rebelo D, Quintas S, Abecasis F. Posterior reversible encephalopathy syndrome: characteristics, diagnostic accuracy, prognostic factors and long-term outcome in a paediatric population. Acta Neurol Belg 2022;122:485-95. [PMID: 34693510 DOI: 10.1007/s13760-021-01819-7] [Reference Citation Analysis]
11 Hun M, Xie M, She Z, Abdirahman AS, Li C, Wu F, Luo S, Han P, Phorn R, Wu P, Luo H, Chen K, Tian J, Wan W, Wen C. Management and Clinical Outcome of Posterior Reversible Encephalopathy Syndrome in Pediatric Oncologic/Hematologic Diseases: A PRES Subgroup Analysis With a Large Sample Size. Front Pediatr 2021;9:678890. [PMID: 34277519 DOI: 10.3389/fped.2021.678890] [Reference Citation Analysis]
12 Seemiller J, Malik MT. Cognitive Sequelae of Central-Variant Posterior Reversible Encephalopathy Syndrome (PRES). Case Rep Neurol Med 2021;2021:8850316. [PMID: 33628545 DOI: 10.1155/2021/8850316] [Reference Citation Analysis]
13 Fischer M, Schmutzhard E. Posterior reversible encephalopathy syndrome. J Neurol. 2017;264:1608-1616. [PMID: 28054130 DOI: 10.1007/s00415-016-8377-8] [Cited by in Crossref: 152] [Cited by in F6Publishing: 96] [Article Influence: 30.4] [Reference Citation Analysis]
14 Chen TH. Childhood Posterior Reversible Encephalopathy Syndrome: Clinicoradiological Characteristics, Managements, and Outcome. Front Pediatr 2020;8:585. [PMID: 33042923 DOI: 10.3389/fped.2020.00585] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
15 Bilir ÖA, Dikme G, Malbora B, Evim MS, Siviş ZÖ, Tüfekçi Ö, Bahadir A, Karaman S, Vural S, Bayhan T, Yarali HN, Celkan T, Özbek NY. Posterior Reversible Encephalopathy Syndrome in Childhood Hematological/Oncological Diseases: Multicenter Results. J Pediatr Hematol Oncol 2021;43:e462-5. [PMID: 33060391 DOI: 10.1097/MPH.0000000000001965] [Reference Citation Analysis]
16 Musioł K, Waz S, Boroń M, Kwiatek M, Machnikowska-Sokołowska M, Gruszczyńska K, Sobol-Milejska G. PRES in the course of hemato-oncological treatment in children. Childs Nerv Syst 2018;34:691-9. [PMID: 29198072 DOI: 10.1007/s00381-017-3664-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
17 Li XY, Huang K, Zhou DH, Li Y, Xu HG, Weng WJ, Xu LH, Fang JP. Severe hypertension is an independent risk factor for posterior reversible encephalopathy syndrome post-hematopoietic cell transplantation in children with thalassemia major. Clin Transplant 2019;33:e13459. [PMID: 30506735 DOI: 10.1111/ctr.13459] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]